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Abstract: A series of novel amphiphilic macromolecules composed of alkyl chains as the hydro-
phobic block and poly(ethylene glycol) as the hydrophilic block were designed to inhibit highly 
oxidized low density lipoprotein (hoxLDL) uptake by synthesizing macromolecules with negatively 
charged moieties (ie, carboxylic acids) located in the two different blocks. The macromolecules 
have molecular weights around 5,500 g/mol, form micelles in aqueous solution with an average 
size of 20−35 nm, and display critical micelle concentration values as low as 10−7 M. Their charge 
densities and hydrodynamic size in physiological buffer solutions correlated with the hydrophobic/
hydrophilic block location and quantity of the carboxylate groups. Generally, carboxylate groups 
located in the hydrophobic block destabilize micelle formation more than carboxylate groups in 
the hydrophilic block. Although all amphiphilic macromolecules inhibited unregulated uptake of 
hoxLDL by macrophages, inhibition efﬁ  ciency was inﬂ  uenced by the quantity and location of 
the negatively charged-carboxylate on the macromolecules. Notably, negative charge is not the 
sole factor in reducing hoxLDL uptake. The combination of smaller size, micellar stability and 
charge density is critical for inhibiting hoxLDL uptake by macrophages.
Keywords: polymeric micelles, amphiphilic macromolecules, highly oxidized low-density 
lipoproteins, scavenger receptor inhibition
Introduction
Atherosclerosis is a process characterized by the buildup of low density lipoproteins 
(LDL) within the vascular intima and ensuing interactions between macrophages and 
their extracellular matrix molecules; it is the single leading cause of death in America 
(Williams and Tabas 1995; Olsson et al 2001; Camejo et al 2002; Thom et al 2006). 
Recent advances in nanotechnology for cardiovascular health are abundant and include 
the application of nanosensors to monitor nitro-oxidative species (oxidative stress) 
produced in the failing heart (Malinski 2005), microarrays or microchips for the study 
of cardiovascular disease (Carella et al 2003), electrospun nanoﬁ  bers as tissue engi-
neered vascular grafts (He, Ma, et al 2005; He, Yong, et al 2005; Ma et al 2005), and 
carbon nanotubes implanted for anticoagulant and antithrombotic properties (Endo 
et al 2005; Meng et al 2005). In contrast to the implantable devices described above, 
an avenue of particular interest in nanotechnology is the use of a “nano-blocker” to 
prevent highly oxidized LDL (hoxLDL) uptake via scavenger receptors. Native LDL 
uptake is mediated by feedback inhibition, whereas binding of hoxLDL to macro-
phage scavenger receptors leads to unregulated cholesterol accumulation and foam 
cell formation. Thus, controlling binding to hoxLDL is an important focus for new 
atherosclerotic treatments (Brown and Goldstein 1983; Steinberg 1997).
Previous work on LDL uptake has focused on synthetic compounds that target and 
bind scavenger receptors, such as SR-A and CD36 that appear to be of primary importance International Journal of Nanomedicine 2007:2(4) 698
Wang et al
in atherogenesis (Yoshiizumi et al 2004; Boullier et al 2005; 
Broz et al 2005; Guaderrama-Diaz et al 2005). For example, 
phosphocholine as a ligand for CD36 has been shown to inhibit 
the binding of hoxLDL in CD36-expressing cells (Boullier 
et al 2005). In addition, sulfatide derivatives for targeting SR-A 
have been shown to reduce acetylated LDL binding and uptake 
(Yoshiizumi et al 2004). Although previous efforts to develop 
scavenger receptor blockers are encouraging, increased efﬁ  ciency 
may be reached through the use of an organized 3D presentation 
of the targeting groups or a multifunctional particle to simultane-
ously target several scavenger receptors (Chnari et al 2006). To 
create a multifunctional nano-blocker, one could exploit the fact 
that all scavenger receptors share an afﬁ  nity for anionic ligands 
(Krieger et al 1993).
We previously reported a unique series of polymers, 
amphiphilic scorpion-like macromolecules (AScM) (Tian et 
al 2004), that self-organize into micelles and not only act as 
a drug delivery system but also decrease hoxLDL’s uptake. 
Previous results show promise for AScMs as a hydrophobic 
drug carrier in terms of low CMC (critical micelle concentra-
tion), low cytotoxicity, high drug loading efﬁ  ciency, and sus-
tained release (Djordjevic et al 2005; Tao and Uhrich 2006). 
These macromolecules consist of three major components: 
poly(ethylene glycol) (PEG), mucic acid, and aliphatic acid 
chains, as seen in Figure 1 (Tian et al 2004). These building 
blocks were chosen because they are naturally occurring or 
biocompatible compounds, and each component is joined 
by potentially biodegradable ester bonds. PEG contributes 
to the hydrophilicity and is used to prevent the non-speciﬁ  c 
adsorption of proteins, mucic acid is a multi-hydroxylated 
saccharide providing reaction sites for further modiﬁ  cation 
of the polymer, and aliphatic acid chains control the polymer 
hydrophobicity.
Previous studies have focused on anionic AScMs that 
spontaneously form micelles at concentrations above the CMC 
(10−7M) (Tian et al 2004). Each AScM is functionalized with 
a carboxylic acid, such that the micellar nanoparticle displays 
anionic charges in an organized and clustered conﬁ  guration. 
The anionic AScMs reduced hoxLDL uptake by up to 80%, and 
both SR-A and CD36 receptors were involved in the uptake of 
the polymers and hoxLDL (Chnari et al 2005, 2006).
In this paper, we present a series of macromolecules that 
maintain two structural elements as previously described: 
mucic acid derivatives as the hydrophobic component and 
PEG as the hydrophilic component. For this investigation, 
the location and number of carboxylic acid groups were 
varied with our synthetic design; carboxylate groups can be 
precisely located in either the hydrophobic or hydrophilic 
domains, or in both domains (Figure 2).
The inhibition ability of these novel macromolecules for 
highly oxidized LDL by macrophages were studied as well 
as their solution properties, including micelle aggregation 
size, CMC and charge density.
Materials and methods
Chemical reagents for synthesis
Heterobifunctional poly(ethylene glycol) (HCl·NH2-
PEG-COOH) with molecular weight of 5000 Da was 
obtained from Nektar (San Carlos, CA). 4-(Dimethylamino)
pyridinium p-toluenesulfonate (DPTS) was prepared as previ-
ously described. Monomethoxy-poly(ethylene glycol) (mPEG) 
with molecular weights of 5000 Da was purchased from 
Sigma-Aldrich. All PEG reagents were dried by azeotropic 
distillation with toluene. β-Glutamic acid, 5-aminoisophthalic 
acid, 4-hydroxybenzoic acid, N-hydroxyl succinimide (NHS), 
triethylamine (99.7%) and 1,3-dicyclohexylcarbodiimide 
(DCC) in 1 M methylene chloride solution were purchased 
from Aldrich and used as received. All other reagents and 
solvents were reagent grade and used as received.
Macromolecules 1CM, 0CM and 1CP
The macromolecules 1CM, 0CM and 1CP were prepared as 
previously described (Tian et al 2004; Chnari et al 2006).
Chemical characterization
Chemical structures and compositions were conﬁ  rmed by 
1H and 13C NMR spectroscopy with samples (∼5–10 mg/ml) 
Aliphatic Acid
20 nm
(a)
(b)
Mucic Acid PEG
Figure 1 Schematic of an amphiphilic macromolecule: at concentrations greater 
than 10-7 M, the unimers in (a) self-aggregate to form micellar nanoparticles (b) 
with hydrodynamic diameters of ~20 nm.International Journal of Nanomedicine 2007:2(4) 699
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dissolved in CDCl3 solvent on Varian 400 MHz spectrom-
eters, using tetramethylsilane as the reference signal. IR 
spectra were recorded on a Mattson Series spectrophotometer 
(Madison Instruments, Madison, WI) by solvent (methylene 
chloride) casting on a KBr pellet. Negative ion-mass spectra 
were recorded with a ThermoQuest Finnigan LCQTM
DUO 
System (San Jose, CA) that includes a syringe pump, an 
optional divert/inject valve, an atmospheric pressure ioniza-
tion (API) source, a mass spectrometer (MS) detector, and 
the Xcalibur data system. Meltemp (Cambridge, Mass) was 
used to determine the melting temperatures (Tm) of all the 
intermediates.
Gel permeation chromatography (GPC) was used to 
obtain molecular weight and polydispersity index (PDI). 
It was performed on Perkin-Elmer Series 200 LC system 
equipped with Pl gel column (5 μm, mixed bed, ID 7.8 mm, 
and length 300 mm) and with a Water 410 refractive index 
detector, Series 200 LC pump and ISS 200 Autosampler. 
Tetrahydrofuran (THF) was the eluent for analysis and sol-
vent for sample preparation. Sample was dissolved into THF 
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Figure 2 Nomenclature for amphiphilic macromolecules, where R in the chemical structures represents a lauroyl carbonyl group.International Journal of Nanomedicine 2007:2(4) 700
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(∼5 mg/ml) and ﬁ  ltered through a 0.45 μm PTFE syringe ﬁ  lter 
(Whatman, Clifton, NJ) before injection into the column at 
a ﬂ  ow rate of 1.0 ml/min. The average molecular weight of 
the sample was calibrated against narrow molecular weight 
polystyrene standards (Polysciences, Warrington, PA).
Synthesis of 1CM1CP
Mucic acid lauroyl derivative (1) was prepared as previously 
described (Tian et al 2004). Compound 1 (0.47 g, 0.50 mmol) 
was mixed with thionyl chloride (20 ml, 270 mmol) and heated 
to reﬂ  ux temperature for 4 hours. After cooling to room tem-
perature, the excess thionyl chloride was removed by rotary 
evaporation. The acyl chloride intermediate was dissolved in 
5.0 ml anhydrous methylene chloride solution with 2.0 ml 
pyridine. Heterobifunctional poly(ethylene glycol) (HCl·NH2-
PEG-COOH) (Mw = 5.0 kDa) (0.50 g, 0.10 mmol) in 5.0 ml 
methylene chloride solution was added dropwise over 2 min. 
After 24 hours stirring at room temperature, the reaction mix-
ture was acidiﬁ  ed by 0.1 N HCl aqueous solution (10 ml × 2) 
and washed by brine (10 ml). The organic portion was dried 
over sodium sulfate, concentrated by rotary evaporator and 
added into diethyl ether (60 ml) to precipitate the product.
1CM1CP was obtained as white waxy solid. 0.52 g, 86% 
yield. 1H NMR (CDCl3) (d ): 5.59 (d, 1H, CH), 5.62 (d, 1H, 
CH) 5.21 (m, 1H, CH), 5.02 (m, 1H, CH), 3.64 (m, ∼0.4kH, 
CH2 on PEG), 2.38 (t, 4H, CH2), 2.21 (t, 4H, CH2), 2.57 
(t, 2H, CH2-COOH of PEG), 1.61 (m, 4H, CH2), 1.51 (m, 
4H, CH2), 1.25 (m, 48H, CH2), 0.88 (t, 12H, CH3). IR (KBr, 
cm−1): 2911 (C-H), 1754 (C = O), 1250, 1105, (C-O). Tm: 
58.0–59.5 °C; GPC: Mw: 5500; PDI: 1.1.
Synthesis of 1BM
Molecule 1 (0.94 g, 1.0 mmol) was mixed with thionyl chloride 
(20 ml, 270 mmol) and heated to reﬂ  ux temperature for 4 hours. 
After cooling to room temperature, the excess thionyl chloride 
was removed by rotary evaporation. A solution of anhydrous 
THF (10 ml) and pyridine (5.0 ml) was added to the reaction 
mixture. 4-Hydroxybenzoic acid (0.55 g, 4.0 mmol) dissolved 
in THF (5.0 ml) was added dropwise over 2 min at 0 °C. The 
reaction was warmed to room temperature and stirred for 
6 hours. The reaction was quenched by adding 1 N HCl (400 
ml) to the reaction mixture. The solid was collected by vacuum 
ﬁ  ltration and obtained as intermediate product, 2.
Intermediate 2 was obtained as white solid, 0.89 g, 75% 
yield. 1H NMR (CDCl3) (d): 8.02 (d, 4H, ArH), 6.95 (d, 4H, 
ArH), 5.59 (m, 2H, CH), 4.94 (m, 2H, CH), 2.32 (m, 8H, 
CH2), 1.49 (m, 8H, CH2), 1.25 (m, 48H, CH2), 0.86 (t, 12H, 
CH3). IR (KBr, cm−1): 2930 (C-H), 1752 (C = O), 1250, 
1148 (C-O), 742 (Aromatic C-C). Tm: 154.5–156.5 °C. FW: 
1167; MS: 1165.5.
Intermediate 2 (0.59 g, 0.50 mmol), mPEG (Mw = 5.0 
kDa, after azeotropic distillation) (0.50 g, 0.10 mmol) and 
DPTS (0.16 g, 0.50 mmol) were dissolved in methylene 
chloride (10 ml) and DMF (1.5 ml) solution. 1 M DCC in 
methylene chloride solution (1.0 ml, 1.0 mmol) was added 
slowly. After 24 hours stirring at room temperature, the side 
product was removed by ﬁ  ltration. The organic solution was 
washed by 0.1 N HCl aqueous solution (10 ml × 2) and brine 
(10 ml). The organic portion was dried over sodium sulfate 
and concentrated by rotary evaporator. Diethyl ether (15 ml) 
was added to precipitate the product 1BM. Additional ethyl 
ether (15 ml × 2) was used to wash the product.
1BM was obtained as white waxy solid. 0.54 g, 88% yield. 
1H NMR (CDCl3) (d): 8.00 (d, 4H, ArH), 6.93 (d, 4H, ArH), 
5.60 (m, 2H, CH), 4.94 (m, 2H, CH), 2.31 (m, 8H, CH2), 1.47 
(m, 8H, CH2), 1.25 (m, 48H, CH2), 0.88 (t, 12H, CH3). IR (KBr, 
cm−1): 2956 (C-H), 1755 (C = O), 1258, 1106 (C-O), 733 (Aro-
matic C-C). Tm: 55.4–56.5 °C. GPC: Mw: 5500; PDI: 1.2.
Synthesis of 2CM
Compound 1CM (0.60 g, 0.10 mmol; after azeotropic dis-
tillation with toluene) and NHS (0.50 g, 0.43 mmol) were 
dissolved in 20 ml methylene chloride and DMF (0.8 ml). 
DCC in methylene chloride (0.50 ml, 0.50 mol) was added 
dropwise under argon. After 12 h, the side product was 
removed by vacuum ﬁ  ltration. The isolated solution was 
directly reacted with β-glutamic acid (0.020 g, 0.43 mmol) 
in the present of triethylamine (1.0 ml, 7.0 mmol). After 8 
hours, the reaction mixture was washed by 0.1 N HCl aque-
ous solution (10 ml × 2), brine (10 ml), dried over sodium 
sulfate and concentrated by rotary evaporator. Diethyl ether 
(15 ml) was added to precipitate the product 2CM.
2CM was obtained as white waxy solid. 0.43 g, 71% 
yield. 1H NMR (CDCl3) (d): 5.62 (m, 2H, CH), 5.08 (m, H, 
CH), 3.66 (m, ∼0.4kH, CH2 on PEG), 2.38 (t, 4H, CH2), 2.21 
(t, 4H, CH2), 1.61 (m, 4H, CH2), 1.51 (m, 4H, CH2), 1.25 (m, 
48H, CH2), 0.88 (t, 12H, CH3). IR (KBr, cm−1): 2925 (C-H), 
1750 (C = O), 1229, 1146 (C-O). Tm: 54.6–55.2 °C. GPC: Mw: 
5500; PDI: 1.2.
Synthesis of 0BM
Compound 1CM (0.60 g, 0.10 mmol; after azeotropic 
distillation with toluene), DPTS (0.31 g, 1.0 mmol) and 
p-phenetidine (0.80 ml, 1.0 mmol) were dissolved in 
methylene chloride (20 ml). DCC in methylene chloride 
(0.20 ml, 0.20 mol) was added dropwise under argon. After International Journal of Nanomedicine 2007:2(4) 701
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12 h, the side product was removed by vacuum ﬁ  ltration. 
The organic portion was washed by 0.1 N HCl solution 
(10 ml × 2), brine (10 ml), dried over sodium sulfate and 
concentrated under rotary evaporator. Diethyl ether (15 
ml) was added to precipitate the product.
0BM was obtained as white waxy solid. 0.56 g, 92% yield. 
1H NMR (CDCl3) (d): 7.21 (d, 2H, ArH), 6.71 (d, 2H, ArH), 
5.78 (d, 1H, CH), 5.49 (d, 1H, CH) 5.38 (m, 1H, CH), 4.95 
(m, 1H, CH), 3.66 (m, ∼0.4kH, CH2 on PEG), 2.38 (t, 4H, 
CH2), 2.21 (t, 4H, CH2), 1.61 (m, 4H, CH2), 1.51 (m, 4H, 
CH2), 1.25 (m, 48H, CH2), 0.88 (t, 12H, CH3). IR (KBr, cm−1): 
2917 (C-H), 1737 (C = O), 1250, 1120 (C-O), 780 (Aromatic 
C-C). Tm: 55.5–57.2 °C.GPC: Mw: 5500; PDI: 1.2.
Dynamic light scattering study
Dynamic light scattering (DLS) analyses were performed 
using a Malvern Instruments Zetasizer Nano ZS-90 instru-
ment (Southboro, MA), with reproducibility being veriﬁ  ed 
by collection and comparison of sequential measurements. 
Polymer solutions (1.0 wt %) in phosphate buffered aqueous 
solution (PBS) (pH 7.4) were prepared. Measurements were 
performed in triplicate at a 90° scattering angle at 25 °C. 
Z-average sizes and standard deviation of polymers in solu-
tion were collected and analyzed.
Fluorescence spectroscopy
Critical micelle concentration (CMC) measurements were 
carried out on a Spex ﬂ  uoroMax (Piscataway, NJ) spectro-
ﬂ  uorometer at 25 °C. Using pyrene as the probe molecule, a 
stock solution at 5.00 × 10−7 M in pH 7.4 PBS solution was 
prepared. Polymer samples were dissolved in the stock pyrene 
solutions then diluted to speciﬁ  c concentrations. Excitation 
was performed from 300 nm to 360 nm, using 390 nm as the 
emission wavelength. Pyrene maximum absorption shifted 
from 332 nm to 334.5 nm upon secondary micelle formation. 
The ratio of absorption of polymer (334.5 nm) to pyrene only 
(332 nm) was plotted as the logarithm of polymer concentra-
tions. The inﬂ  ection point of the curves was taken as CMC.
Zeta potential
Charge densities of all polymeric micelle solutions were 
measured by the zeta potential method using a Malvern 
Instruments Zetasizer Nano ZS-90 instrument (Southboro, 
MA), with reproducibility veriﬁ  ed by collection and com-
parison of sequential measurements. Instrument settings and 
calculation parameters were deﬁ  ned as temperature at 25 °C, 
dispersant viscosity at 0.89 cP and dielectric constant of 
78.5. The viscosity of the samples was estimated to be that 
of water. All the samples measured were prepared at 10−4 M 
in PBS solution (pH 7.4).
Preparation of micelles for in vitro testing
Micelles were freshly prepared and used within 7 days at 
10−4 M in serum-free RPMI medium (without FBS). The 
micelles were then combined with serum-free RPMI and/or 
hoxLDL to create a ﬁ  nal macromolecule concentration of 
10−6 M.
Lipoprotein model: LDL oxidation
Highly oxidized LDL (hoxLDL) was prepared within ﬁ  ve 
days of each experiment. BODIPY-labeled and unlabeled 
human plasma derived LDL (Molecular Probes, OR) was oxi-
dized for 18 hours in the presence of 10 μM CuSO4 (Sigma) at 
37 °C and 5% CO2 (Oorni et al 1997; Chang et al 2001). The 
oxidation was stopped with 0.01% w/v EDTA. Thiobarbitu-
ric acid reactive substances (TBARS), lipid hydroperoxide 
(LPO), conjugated dienes, and electrophoretic mobility (with 
the help of Dr. Schaich) was performed to ensure accurate 
and consistent oxidation levels were attained.
LDL internalization
The internalization of hoxLDL by macrophage cells was 
assayed by incubating fluorescently labeled hoxLDL 
(10ug/mL) with IC21 macrophages for 24 hours at 37 °C 
and 5% CO2. The cells were then washed twice with serum-
free RPMI medium. The cell-associated ﬂ  uorescence was 
measured by acquiring images on a confocal microscope 
(Sun Microsystems, Santa Clara, CA) and quantifying the 
ﬂ  uorescence intensity using Image Pro Plus 5.1 software 
(Media Cybernetics, San Diego, CA) and normalized to 
cell number.
Cell culture
IC21 macrophages, a well established differentiated murine 
cell line acquired from ATCC, were used for all studies. 
The cells have morphology and structure comparable to 
that of freshly isolated activated mouse peritoneal mac-
rophages, and have demonstrated LDL receptor activity 
(Traber et al 1981). IC21 cells degrade acetylated LDL 
and thus an acceptable model for the study of cholesterol 
and lipoprotein metabolism by macrophages. These cells 
are an economical alternative to freshly isolated mouse 
peritoneal macrophages. The cells were propagated with 
RPMI media containing 0.4 mM Ca2+ and Mg2+, (ATCC) 
and supplemented with 10% fetal bovine serum (FBS). 
The cells were maintained in an incubator with 5% CO2 at International Journal of Nanomedicine 2007:2(4) 702
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37 °C and harvested prior to reaching conﬂ  uence. All cell 
assays were performed in triplicate.
Results
Synthesis of the macromolecules
Several different amphiphilic macromolecules were synthe-
sized in which the number and location of carboxylate groups 
were modiﬁ  ed (Figure 3).
The 1CM, 0CM and 1CP were prepared as described 
in previous work (Chnari et al 2006). The design rationale 
for each macromolecule is as follows. 1CM1CP probes the 
combinatorial activity of a carboxylic acid present in both the 
hydrophilic and hydrophobic blocks of AScMs. It was suc-
cessfully synthesized by coupling (NH2-PEG-COOH) with 
mucic acid acyl derivatives (1) activated as acyl chloride. 
1BM was prepared to investigate any differences between 
aliphatic and aromatic carboxylates, in this molecule, car-
boxylates are located in the hydrophobic domain. Our ﬁ  rst 
attempt to generate an aromatic carboxylate group was not 
successful; we attempted to couple molecule 1CM directly 
with 4-hydroxybenzoic acid. However, the low nucleophilic-
ity of the phenol yielded unacceptably low coupling efﬁ  cien-
cies. Instead, we prepared the symmetric intermediate (2), 
which was easy to purify and then successfully coupled with 
mPEG-OH (5k) to obtain 1BM. The macromolecule 0BM 
was prepared as a control for 1BM and synthesized through 
direct esteriﬁ  cation of the carboxylate on polymer 1CM. 
2CM was designed to study how two carboxylates in the 
hydrophobic block may synergistically inﬂ  uence hoxLDL 
uptake. Overall, all coupling reactions were achieved in 
reasonably high coupling efﬁ  ciency and high yield. All seven 
macromolecules displayed a comparable molecular weights 
(∼5500) and melting temperatures (∼56 °C).
Physical properties of the AScMs
The molecules are similar in size (23–27 nm) in aque-
ous media (Table 1) except for 2CM, which is slightly 
larger (∼35 nm), and all macromolecules display mono-
modal size distributions. The CMC values are in similar 
range, again with the exception of 2CM, which has the 
Figure 3 Synthetic outline for the amphiphilic macromolecules.
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highest CMC value (1.8 × 10−6 M); the CMC values is 
approximately 7 times larger than the CMC of 1CM, for 
example.
With respect to charge density, the polymers 0CM 
and 0BM are charge neutral yet still register slightly 
negative zeta potential values (Table 1). 1CM, 1CP and 
2CM, display a similar zeta potential value (∼ –10mV). 
Solutions of 1CM1CP display the most negative zeta 
potential (∼ –20 mV), which is double the values for 
1CM, 1CP and 2CM.
Highly-oxidized LDL uptake inhibition 
studies
At 24 hours, hoxLDL uptake in macrophages was signiﬁ  cantly 
reduced in the presence of the anionic nano-sized micelles, 
namely 1CM, 1CP, 1CM1CP, 2CM and 1BM (Figure 4). The 
degree of uptake was normalized to controls without polymers 
present; positive controls included the neutral micelles (0CM 
and 0BM). Among the effective hoxLDL uptake inhibitors, the 
1CM1CP micelles resulted in the highest inhibition of hoxLDL 
uptake, reducing hoxLDL internalization more signiﬁ  cantly 
(p < 0.05) than all the other polymer micelles.
Discussion
Synthesis and solution-based properties
Micelle formation and nanoscale size are both important in 
hoxLDL inhibition; our hypothesis about the macrophage 
receptors is that they are slightly positively charged, such that 
nanoscale micelles with a high density of negative charges are 
more accessible via electrostatic interactions.
All seven amphiphilic macromolecules self-organized to 
form micelles in aqueous solutions, as indicated by the CMC 
values near 10–6 to10–7 M. The critical micelle concentration 
(CMC) is a crucial parameter that measures the stability 
of amphiphiles. All amphiphilic macromolecules have 
relatively low CMC values (from 10–6 to 10–7 M), a critical 
characteristic for biological applications as low CMC values 
indicate higher stability upon dilution in blood plasma. Most 
of the AScMs have similar CMC values, indicating that a 
single negative charge does not prevent self-aggregation into 
Table 1 Particle sizes, critical micelle concentrations and zeta-potential values of the amphiphilic macromolecules at pH 7.4
 1CM  0CM  1CP  1CM1CP  1BM  2CM  0BM
Z-average size  23.2 ± 5.2 27.4 ± 2.5 23.6 ± 5.9 23.1 ± 4.8 23.4 ± 3.7 35.1 ± 4.7 23.9 ± 4.2
(nm) at 10−4M            
CMC (M)  3.2 × 10−7 5.7  × 10−7 1.0  × 10−7 8.8  × 10−7 7.0  × 10−7 1.8  × 10−6 7.8  × 10−7
Zeta-potential  −10.4  −0.47  −9.60  −20.1  −15.3  −9.20  −3.46
(mV) at 10−4M              
Figure 4 After 24 hours, percent of hoxLDL uptake by macrophages in the presence of amphiphilic macromolecules, compared to hoxLDL alone. Macromolecule concen-
tration is 10−6 M.
* represents a signiﬁ  cant decrease (P < 0.05) in comparison to hoxLDL alone.
# represents a signiﬁ  cant decrease (P < 0.05) in comparison to hoxLDL with 1BM or 1CM.
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micelles at pH 7.4. Notably, molecule 2CM has a relatively 
higher CMC value compared to the other macromolecules. 
Two aliphatic carboxylate groups on hydrophobic domain of 
polymeric micelles appear to slightly inhibit micelle forma-
tion, possibly due to the repulsion between adjacent negative 
charges formed in slightly basic (pH 7.4) solution.
Similar to the CMC data, molecule 2CM displays dif-
ferent behavior than the other macromolecules in terms 
of size. The micellar sizes of all AScMs, except 2CM, are 
approximately 20 nm (Table 1), indicating that a single 
negative charge does not change the micelle aggregation 
size. In contrast, molecule 2CM is larger in size (35 nm) 
than the other macromolecules. Compared with the other 
macromolecules, 2CM is relatively less hydrophobic due to 
the presence of two carboxylates in the hydrophobic block, 
resulting in a “looser” aggregation or larger size.
Zeta potential measurements determines the surface charge 
densities, which is expected to be negative for the carboxyl-
ate-containing amphiphilic macromolecules. The neutral 
macromolecules (0CM and 0BM) registered slight negative 
charges (–3.5 mV and –0.4 mV, respectively). 1BM has a 
slightly more negative zeta potential than 1CM as benzoic 
acid is more acidic than the aliphatic carboxylic acid. Notably, 
1CM1CP has the most negative value (–20 mV) likely because 
it contains two carboxylate groups, one in the hydrophobic 
block and one in the hydrophilic block. Molecule 2CM also 
bears two negative charges, but both carboxylates reside within 
the hydrophobic core. As a result, the charge density does not 
increase in comparison with 1CM.
Inhibition of hoxLDL uptake by 
amphiphilic nanoparticles
The uncontrollable internalization of hoxLDL by macrophage 
cells is an essential aspect in atherosclerotic progression 
(Patel et al 2000). It has previously been proven that 1CM 
molecules signiﬁ  cantly reduce hoxLDL uptake through 
blockage of SR-A and CD36 scavenger receptors (Chnari 
et al 2006). The mechanism that leads to enhanced hoxLDL 
internalization with the anionic micelle particles relative 
to similar neutral polymers is not completely understood; 
therefore, nanoparticles with anionic groups placed in precise 
locations were prepared and evaluated.
The key ﬁ  nding in this study is that charge alone does not 
determine the extent of hoxLDL internalization reduction by 
macrophage cells. 1CM1CP is the most effective macromol-
ecule in reducing hoxLDL internalization, while the similarly 
charged 2CM reduced hoxLDL uptake even less than 1CM. 
We hypothesize that the size of the 2CM might modulate the 
behavior of nanoparticle binding to the scavenger receptors. 
Scavenger receptors typically bind to particles and are then 
internalized through clathrin-coated pits (Platt and Gordon 
2001). Previous studies have shown that the increased size of 
PEGylated nanoparticles, nanoscale iron oxide contrast agents, 
and colloids can promote their scavenger receptor mediated 
uptake in macrophages (Moghimi and Szebeni 2003; Raynal 
et al 2004; Vonarbourg et al 2006). However, consequences 
for scavenger receptor ligands such as hoxLDL were not 
evaluated. The exact mechanism for micellar nanoparticle 
binding in our system is not clear, but we offer two potential 
mechanisms. For example, the larger 2CM micellar nanopar-
ticles (∼35 nm) may promote the internalization of scavenger 
receptors in relation to the smaller diameter of 1CM1CP 
micelle (23.1 nm) and cooperatively facilitate hoxLDL uptake 
through mechanisms not yet clear. Alternately, the larger 
nanoparticles may interfere with folding and internalization 
of scavenger receptors. In either case, the major result is that 
the reduction in hoxLDL internalization is not addressed from 
charge alone: The 1CM decreases hoxLDL internalization 
more signiﬁ  cantly than 2CM, even though both exhibit similar 
values of zeta potential (∼ −10 mV).
Conclusion
Several amphiphilic scorpion-like macromolecules were 
synthesized to investigate how the number and location of 
carboxylate groups inﬂ  uence hoxLDL inhibition. All mac-
romolecules self-organized into stable nanoscale micelles in 
an aqueous environment. Carboxylate groups located in the 
hydrophobic block inﬂ  uenced micelle size and CMC more 
than carboxylate groups in the hydrophilic block. Overall, 
molecule 1CM1CP demonstrates several unique characteris-
tics: small size (23.1 nm), low CMC (∼10−7 M) and high zeta 
potential (∼ –20 mV). The combination of size, nanoparticle 
stability and charge density appear to be critical for inhibition 
hoxLDL uptake by macrophages.
Future investigations will focus on identifying the mode 
of micelle internalization, with a view to support or disprove 
the hypothesis that micelle diameter affects scavenger 
receptor occupancy. Mixed micelles will also be tested to 
determine whether a micelle can be created that will decrease 
hoxLDL internalization even more signiﬁ  cantly than the 
1CM1CP alone.
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